Ovarian Cancer

Daily or near daily aspirin use reduced the risk for nonmucinous ovarian cancer across most strata of genetic risk based on a polygenic score, according to a case-control study published in JAMA Network Open.

Clinicians should advocate for opportunistic salpingectomy among patients undergoing surgery for benign pelvic diseases to prevent ovarian cancer, according to a consensus statement from the Ovarian Cancer Research Alliance.

Longer duration of ovulation across the life span was associated with a greater risk for epithelial ovarian cancer, according to data published in the Journal of the National Cancer Institute.

Up to 8 months before diagnosis, women with ovarian cancer purchased more over-the-counter pain and indigestion medications vs. women without ovarian cancer, according to findings of an observational case-control study.

Researchers at Cold Spring Harbor Laboratory have developed software that correctly deduces continental ancestry from tumor DNA and RNA.

Presence of certain bacteria in the microbiome may indicate early-stage ovarian cancer, according to data published in Scientific Reports.

World Cancer Day is observed annually on Feb. 4.

This year, women’s health care providers have faced challenges that developed throughout the year, from the lingering COVID-19 pandemic to a changing legal landscape.

This year, researchers found that of patients with high-risk, early-stage ovarian cancer, 72% had one or more symptoms and 28% were asymptomatic.

During their lifetime, one in 70 women will receive a diagnosis of ovarian cancer, which is the second most common gynecologic cancer in the United States, according to Memorial Sloan Kettering Cancer Center.